PME signs 7-Year A$90M Deal with Beth Israel Lahey Health
Open PDF
| Stock | Pro Medicus Ltd (PME.ASX) |
|---|---|
| Release Time | 18 May 2026, 9:13 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Pro Medicus Signs A$90M Deal with Beth Israel Lahey Health
Key Points
- PME signs 7-year, A$90M contract with Beth Israel Lahey Health
- Contract covers Visage 7 Viewer, Workflow, and Open Archive
- Visage 7 platform to be implemented in the cloud
- Go-live targeted for Q1 2027
Full Summary
Pro Medicus Limited [ASX: PME], a leading healthcare informatics company, has signed a 7-year, A$90M contract with Boston-based Beth Israel Lahey Health. The contract is for the implementation of the Visage 7 Enterprise Imaging Platform, including Visage 7 Viewer, Visage 7 Workflow, and Visage 7 Open Archive. The Visage 7 platform will be implemented in the cloud and is expected to go live in Q1 2027. The contract is based on a transactional licensing model with potential upside.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In